HLA ANTIBODIES PRESENT IN THE SERA OF SENSITIZED PATIENTS AWAITING RENAL TRANSPLANT ARE ALSO REACTIVE TO SWINE LEUKOCYTE ANTIGENS1,2
- 1 October 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 66 (8) , 1074-1080
- https://doi.org/10.1097/00007890-199810270-00018
Abstract
To determine whether preformed HLA alloantibodies present in the sera of patients awaiting kidney transplantation will be detrimental to a potential porcine xenograft, we tested their cross-reactivity to swine leukocyte antigens (SLA). Sera obtained from patients with varying levels of HLA sensitization (high panel-reactive antibodies >70%, n=7; moderate panel-reactive antibodies 30-40%, n=2) were analyzed. Pooled normal human AB sera and sera from nonsensitized patients (n=3) served as negative control. IgG was purified by protein-G chromatography, and xenoreactive natural antibodies (XNA) were depleted by passing the IgG through a series of melibiose and thyroglobulin-agarose columns. The elimination of XNA from HLA IgG preparations was confirmed by GS-IB4 lectin blocking assay and by an ELISA. IgG isolated from normal AB serum and three nonsensitized patients, which was depleted of XNA (HLA-IgG), did not react to human or porcine lymphocytes (peripheral blood mononuclear cells; PBMC) either by flow cytometry or by complement-dependent microcytotoxicity assays. However, HLA-IgG isolated from nine sensitized patients were reactive to a panel of porcine peripheral blood lymphocytes (n=6) by flow cytometry (>50 mean channel shift) and in complement-dependent microcytotoxicity assays in addition to their reactivity to human PBMC. The binding of HLA-IgG to porcine PBMC was significantly reduced by preabsorption with pooled human platelet concentrate. Further, the HLA IgG showed recognition of 45-kDa affinity-purified SLA class I on Western blots. This study demonstrates that HLA antibodies present in the sera of sensitized individuals can cross-react with SLA. Thus, xenotransplantation of porcine organs into HLA-sensitized patients has the potential to be rejected by humoral mechanisms. Testing to avoid such cross-reactive antibodies should be considered.Keywords
This publication has 32 references indexed in Scilit:
- SOLUBLE HLA ANTIGENS AND ELISA—A NEW TECHNOLOGY FOR CROSSMATCH TESTING1Transplantation, 1995
- Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosisNephrology Dialysis Transplantation, 1995
- SPECIFIC INHIBITION OF HLA CLASS I AND II ANTIBODIES BY SOLUBLE ANTIGENS—A METHOD FOR THE IDENTIFICATION OF ANTIBODY SPECIFICITY IN SERA FROM ALLOIMMUNIZED INDIVIDUALSTransplantation, 1994
- IgG ANTIBODIES AGAINST AN HLA ANTIGEN ARE ASSOCIATED WITH ACTIVATED CYTOTOXIC T CELLS AGAINST THIS ANTIGEN, IgM ARE NOTTransplantation, 1994
- ENZYME-LINKED IMMUNOASSAY FOR ANTI-HLA ANTIBODIES—AN ALTERNATIVE TO PANEL STUDIES BY LYMPHOCYTOTOXICITYTransplantation, 1993
- OUTCOME OF CARDIAC TRANSPLANT RECIPIENTS WITH A POSITIVE DONOR-SPECIFIC CROSSMATCH—PRELIMINARY RESULTS WITH PLASMAPHERESISTransplantation, 1992
- REMOVAL OF LYMPHOCYTOTOXIC ANTIBODIES BY PRETRANSPLANT IMMUNOADSORPTION THERAPY IN HIGHLY SENSITIZED RENAL TRANSPLANT RECIPIENTSTransplantation, 1991
- Laboratory and clinical management of the highly sensitized organ transplant recipientHuman Immunology, 1989
- CHARACTERIZATION OF LYMPHOCYTOTOXIC ANTIBODIES CAUSING A POSITIVE CROSSMATCH IN RENAL TRANSPLANTATIONTransplantation, 1989
- IMMUNOGLOBULIN CLASS AND SPECIFICITY OF ANTIBODIES CAUSING POSITIVE T CELL CROSSMATCHESTransplantation, 1986